Wuhan Dazhong Dental Medical Co., Ltd. (HKG:2651)
Hong Kong · Delayed Price · Currency is HKD 29.08
+2.88 (10.99%)
Sep 2, 2026, 3:42 PM HKT
HKG:2651 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2016 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '16 Dec 31, 2016 |
| 366.35 | 371.57 | 407.08 | 441.84 | 409.44 | 81.18 | |
Revenue Growth | -5.66% | -8.72% | -7.87% | 7.91% | 404.37% | 39.35% |
Cost of Revenue | 229.48 | 231.5 | 254.74 | 273.62 | 260.97 | 38.03 |
Gross Profit | 136.87 | 140.07 | 152.34 | 168.23 | 148.47 | 43.15 |
Selling, General & Admin | 68.48 | 71.6 | 75.35 | 77.24 | 75.7 | 29.01 |
Research & Development | 8.39 | 9.06 | 6.67 | 6.82 | 6.62 | - |
Other Operating Expenses | - | - | - | - | - | 0.2 |
Operating Expenses | 76.88 | 80.66 | 82.02 | 84.06 | 82.32 | 29.21 |
Operating Income | 59.99 | 59.42 | 70.32 | 84.17 | 66.16 | 13.94 |
Interest Expense | -3.41 | -4.31 | -5.33 | -5.51 | -6.68 | - |
Interest & Investment Income | 0.35 | 0.35 | 2.45 | 3.56 | 3.07 | - |
Other Non Operating Income (Expenses) | -9.13 | -1.34 | 1.05 | -0.75 | 0.14 | -0.21 |
EBT Excluding Unusual Items | 47.79 | 54.11 | 68.49 | 81.47 | 62.69 | 13.73 |
Gain (Loss) on Sale of Investments | 0.41 | 0.41 | - | -0.12 | - | - |
Gain (Loss) on Sale of Assets | -0.31 | -0.31 | -0.51 | -0.52 | 1.4 | - |
Asset Writedown | - | - | - | - | - | -0.03 |
Other Unusual Items | 3.62 | 3.62 | 2.84 | -1.92 | -0.58 | - |
Pretax Income | 51.51 | 57.84 | 70.82 | 78.91 | 63.51 | 13.7 |
Income Tax Expense | 6.37 | 7.23 | 8.32 | 11.87 | 7.06 | 3.43 |
Earnings From Continuing Operations | 45.14 | 50.61 | 62.5 | 67.04 | 56.45 | 10.28 |
Minority Interest in Earnings | -20.53 | -22.43 | -20.58 | -16.97 | -13.11 | - |
Net Income | 24.61 | 28.18 | 41.92 | 50.07 | 43.34 | 10.28 |
Preferred Dividends & Other Adjustments | -2.37 | - | 5.38 | 6.14 | 5.32 | - |
Net Income to Common | 26.98 | 28.18 | 36.53 | 43.93 | 38.03 | 10.28 |
Net Income Growth | -15.93% | -22.88% | -16.83% | 15.52% | 270.06% | 29.61% |
Shares Outstanding (Basic) | 52 | 44 | 39 | 41 | 41 | 29 |
Shares Outstanding (Diluted) | 52 | 44 | 39 | 41 | 41 | 29 |
Shares Change | 49.34% | 12.05% | -5.09% | - | 44.15% | 44.01% |
EPS (Basic) | 0.52 | 0.64 | 0.94 | 1.07 | 0.92 | 0.36 |
EPS (Diluted) | 0.52 | 0.64 | 0.94 | 1.07 | 0.92 | 0.36 |
EPS Growth | -43.70% | -31.17% | -12.37% | 15.52% | 156.72% | -10.00% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2016 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '16 Dec 31, 2016 |
Free Cash Flow | 71.41 | 80.79 | 77.22 | 130.48 | 105.97 | -6.52 |
Free Cash Flow Per Share | 1.37 | 1.85 | 1.98 | 3.17 | 2.58 | -0.23 |
Dividend Per Share | 0.668 | 0.668 | - | - | - | - |
Dividend Growth | - | - | - | - | - | - |
Gross Margin | 37.36% | 37.70% | 37.42% | 38.07% | 36.26% | 53.15% |
Operating Margin | 16.38% | 15.99% | 17.27% | 19.05% | 16.16% | 17.17% |
Profit Margin | 7.37% | 7.58% | 8.97% | 9.94% | 9.29% | 12.66% |
Free Cash Flow Margin | 19.49% | 21.74% | 18.97% | 29.53% | 25.88% | -8.04% |
EBITDA | 78.18 | 80.27 | 91.38 | 107.27 | 90.2 | 17.65 |
EBITDA Margin | 21.34% | 21.60% | 22.45% | 24.28% | 22.03% | 21.74% |
D&A For EBITDA | 18.19 | 20.86 | 21.06 | 23.1 | 24.05 | 3.71 |
EBIT | 59.99 | 59.42 | 70.32 | 84.17 | 66.16 | 13.94 |
EBIT Margin | 16.38% | 15.99% | 17.27% | 19.05% | 16.16% | 17.17% |
Effective Tax Rate | 12.37% | 12.50% | 11.74% | 15.04% | 11.11% | 25.01% |
Revenue as Reported | - | - | - | - | - | 81.18 |
Advertising Expenses | - | 36.02 | 32.4 | 37.15 | 34.45 | - |